|
|
Naprelan (Naproxen Sodium) Controlled Release Tablets
|
 |
Central nervous system agent
|
 |
Analgesic
|
 |
To relieve pain caused by tendinitis, arthritis, soft tissue injuries, menstrual cramps, and other conditions.
|
 |
Adults and teenagers: 750 mg to 1000 mg once daily. Do not exceed 1000 mg/day.
|
 |
Category B
|
 |
Heartburn, Indigestion, Constipation, Diarrhea, headache, dizziness, drowsiness, nausea, vomiting, water retention, rash, itching, Ringing in the Ears, wheezing, elevated liver enzymes, GI bleeding, peptic ulcer
|
Pregnancy Risk Categories defined:
A: Studies in pregnant women failed to show a risk to the fetus in the first
trimester - with no evidence of risk in the later trimesters.
B: Animals studies indicate no adverse effect to the fetus, but there are no adequate,
clinical studies in pregnant women.
C: Animal studies have shown an adverse effect on the fetus, but there are no adequate,
clinical studies in humans. Despite potential risks, the drug may be useful in pregnant
women.
D: There is evidence of risk to the human fetus, but the potential benefits of use in
pregnant women may be acceptable, despite potential risks.
X: Studies in animals or humans show fetal abnormalities, or adverse reaction reports
indicate evidence of fetal risk. Warning: the risks involved clearly outweigh any
potential benefit from using the drug in pregnant women, regardless of trimester.
NR: Not rated (i.e., no information available at this time as to the potential
risks or benefits).
|
| | |
If you want your friend to read or know about this article, Click here
 |
|
|
